The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Serum Adipocyte Fatty Acid–Binding Protein as a New Biomarker Predicting the Development of Type 2 Diabetes
Open accessAbstract
OBJECTIVE— Adipocyte fatty acid–binding protein (A-FABP) is abundantly expressed in adipocytes and plays a role in glucose homeostasis in experimental animals. We have previously shown that circulating A-FABP levels are associated with the metabolic syndrome, which confers an increased risk of type 2 diabetes. Here we investigated whether serum A-FABP levels could predict the development of diabetes in a 10-year prospective study. RESEARCH DESIGN AND METHODS— Baseline serum A-FABP levels were measured with an enzyme-linked immunosorbent assay in 544 nondiabetic subjects, recruited from the Hong Kong Cardiovascular Risk Factor Prevalence Study cohort, who were followed prospectively to assess the development of type 2 diabetes. The role of A-FABP in predicting the development of type 2 diabetes over 10 years was investigated using Cox regression analysis. RESULTS— At baseline, serum sex-adjusted A-FABP levels were higher in subjects with impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) (P < 0.00001 versus normal glucose tolerance) and correlated positively with adverse cardiometabolic risk factors. Over 10 years, 96 subjects had developed type 2 diabetes. High baseline A-FABP was predictive of type 2 diabetes, independent of obesity, insulin resistance, or glycemic indexes (relative risk [RR] 2.25 [95% CI 1.40–3.65]; P = 0.001; above versus below sex-specific median). High A-FABP levels remained an independent predictor of type 2 diabetes in the high-risk IGT/IFG subgroup (adjusted RR 1.87 [1.12–3.15]; P = 0.018). CONCLUSIONS— Serum A-FABP was associated with glucose dysregulation and predicted the development of type 2 diabetes in a Chinese cohort.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799
Epidemic obesity and type 2 diabetes in Asia
Yoon, K.-H., Lee, J.-H., Kim, J.-W., Cho, J. H., Choi, Y.-H., Ko, S.-H., Zimmet, P., & Son, H.-Y. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69703-1 · Cited by 1,580
Adiponectin and development of type 2 diabetes in the Pima Indian population
Lindsay, R. S., Funahashi, T., Hanson, R. L., Matsuzawa, Y., Tanaka, S., Tataranni, P. A., Knowler, W. C., & Krakoff, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09335-2 · Cited by 1,094
Hotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 918
The Metabolic Syndrome as Predictor of Type 2 Diabetes
Lorenzo, C., Okoloise, M., Williams, K., Stern, M. P., & Haffner, S. M. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3153 · Cited by 803
Xu, A., Wang, Y., Xu, J. Y., Stejskal, D., Tam, S., Zhang, J., Wat, N. M., Wong, W. K., & Lam, K. S. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.062463 · Cited by 602
Self-citationMaeda, K., Cao, H., Kono, K., Gorgun, C. Z., Furuhashi, M., Uysal, K. T., Cao, Q., Atsumi, G., Malone, H., Krishnan, B., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.008 · Cited by 477
Vogel Hertzel, A., & Bernlohr, D. A. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00257-5 · Cited by 404
Xu, A., Tso, A. W. K., Cheung, B. M. Y., Wang, Y., Wat, N. M. S., Fong, C. H. Y., Yeung, D. C. Y., Janus, E. D., Sham, P. C., & Lam, K. S. L. (2007) · Circulation · doi:10.1161/circulationaha.106.647503 · Cited by 360
Self-citationPhysiological properties and functions of intracellular fatty acid-binding proteins
Coe, N. R., & Bernlohr, D. A. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00205-1 · Cited by 329
Improved Glucose and Lipid Metabolism in Genetically Obese Mice Lacking aP2
Uysal, K. T., Scheja, L., Wiesbrock, S. M., Bonner‐Weir, S., & Hotamışlıgil, G. S. (2000) · Endocrinology · doi:10.1210/en.141.9.3388 · Cited by 324
Fatty Acid Binding Proteins—The Evolutionary Crossroads of Inflammatory and Metabolic Responses
Makowski, L., & Hotamisligil, G. S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.9.2464s · Cited by 311
Coe, N. R., Simpson, M. A., & Bernlohr, D. A. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32133-7 · Cited by 296
Tuncman, G., Erbay, E., Hom, X., De Vivo, I., Campos, H., Rimm, E. B., & Hotamisligil, G. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602178103 · Cited by 277
Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.
Scheja, L., Makowski, L., Uysal, K. T., Wiesbrock, S. M., Shimshek, D. R., Meyers, D. S., Morgan, M., Parker, R. A., & Hotamisligil, G. S. (1999) · Diabetes · doi:10.2337/diabetes.48.10.1987 · Cited by 217
Yeung, D. C. Y., Xu, A., Cheung, C. W. S., Wat, N. M. S., Yau, M. H., Fong, C. H. Y., Chau, M. T., & Lam, K. S. L. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.146274 · Cited by 213
Self-citationInteraction of rat hormone-sensitive lipase with adipocyte lipid-binding protein
Shen, W.-J., Sridhar, K., Bernlohr, D. A., & Kraemer, F. B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5528 · Cited by 198
Boord, J. B., Maeda, K., Makowski, L., Babaev, V. R., Fazio, S., Linton, M. F., & Hotamisligil, G. S. (2004) · Circulation · doi:10.1161/01.cir.0000141735.13202.b6 · Cited by 193
Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome?
Stejskal, D., & Karpíšek, M. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01696.x · Cited by 129
Janus, E. D., Wat, N. M. S., Lam, K. S. L., Cockram, C. S., Siu, S. T. S., Liu, L. J., & Lam, T. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00376.x · Cited by 126
Self-citationShaughnessy, S., Smith, E. R., Kodukula, S., Storch, J., & Fried, S. K. (2000) · Diabetes · doi:10.2337/diabetes.49.6.904 · Cited by 105
Investigation of in vivo fatty acid metabolism in AFABP/aP2−/−mice
Baar, R. A., Dingfelder, C. S., Smith, L. A., Bernlohr, D., Wu, C., Lange, A. J., & Parks, E. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00256.2004 · Cited by 98
Cao, H., Maeda, K., Görgün, C. Z., Kim, H., Park, S., Shulman, G. I., Kim, J. K., & Hotamışlıgil, G. S. (2006) · Diabetes · doi:10.2337/db05-1496 · Cited by 92
Tan, K. C. B., Wat, N. M. S., Tam, S., Janus, E. D., Lam, T., & Lam, K. S. L. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2323 · Cited by 87
Self-citationTso, A. W. K., Sham, P. C., Wat, N. M. S., Xu, A., Cheung, B. M. Y., Rong, R., Fong, C. H.-Y., Xu, J. Y., Cheng, K. K. Y., Janus, E. D., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0324-2 · Cited by 74
Self-citationCentral obesity predicts the worsening of glycemia in southern Chinese
Wat, N., Lam, T., Janus, E., & Lam, K. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801834 · Cited by 59
Self-citationPhysical Association between the Adipocyte Fatty Acid-binding Protein and Hormone-sensitive Lipase
Smith, A. J., Sanders, M. A., Thompson, B. R., Londos, C., Kraemer, F. B., & Bernlohr, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410301200 · Cited by 57
The relation of adipose tissue to cardiometabolic risk
Pi-Sunyer, X. (2006) · Clinical cornerstone · doi:10.1016/s1098-3597(06)80040-2 · Cited by 41
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
Furuhashi, M., & Hotamisligil, G. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2589 · Cited by 1,785
Ma, R. C. W., & Chan, J. C. N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12098 · Cited by 827
Metabolic functions of FABPs—mechanisms and therapeutic implications
Hotamisligil, G. S., & Bernlohr, D. A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.122 · Cited by 712
Goldberg, R. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2534 · Cited by 644
Furuhashi, M., Saitoh, S., Shimamoto, K., & Miura, T. (2014) · Clinical Medicine Insights: Cardiology · doi:10.4137/cmc.s17067 · Cited by 489
Metadata
- Authors
- Tso, A. W. K., Xu, A., Sham, P. C., Wat, N. M. S., Wang, Y., Fong, C. H. Y., Cheung, B. M. Y., Janus, E. D., & Lam, K. S. L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-10-01
- Volume
- 30
- Issue
- 10
- Pages
- 2667-2672
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2113570079
- Cited by
- 291
- References
- 32
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.